# Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer

> **NCT00888823** · PHASE1,PHASE2 · COMPLETED · sponsor: **AHS Cancer Control Alberta** · enrollment: 13 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **RADIATION:** Stereotactic Radiotherapy

## Key facts

- **NCT ID:** NCT00888823
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2014-02
- **Final completion:** 2014-06
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2016-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00888823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00888823, "Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT00888823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
